Is PEYE or JNJ a better dividend investment in 2026?

PEYE currently yields 102.56% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: PEYE offers higher current income.

What is the dividend yield difference between PEYE and JNJ?

PEYE has a forward dividend yield of 102.56% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 99.20 percentage points.

Home › Compare › PEYE vs JNJ

PEYE vs JNJ: Dividend Comparison 2026

PEYE yields 102.56% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PEYE wins by $4.30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PEYE

● Live price

102.56%

Share price

$1.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.32M

Annual income

$1,481,817.76

Full PEYE calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — PEYE vs JNJ

📍 PEYE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PEYE	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PEYE + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PEYE pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEYE

Annual income on $10K today (after 15% tax)

$8,717.95/yr

After 10yr DRIP, annual income (after tax)

$1,259,545.10/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, PEYE beats the other by $1,258,841.48/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEYE + JNJ for your $10,000?

PEYE: 50%JNJ: 50%

100% JNJ50/50100% PEYE

Portfolio after 10yr

$2.17M

Annual income

$741,322.77/yr

Blended yield

34.13%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PEYE

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEYE buys

JNJ buys

No recent congressional trades found for PEYE or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPEYEJNJ

Forward yield	102.56% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$4.32M	$20.0K ✓
Annual income after 10y	$1,481,817.76 ✓	$827.78
Total dividends collected	$3.87M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PEYE vs JNJ ($10,000, DRIP)

Year	PEYE Portfolio	PEYE Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$20,956	$10,256.41	$10,676	$355.77	+$10.3K → PEYE
2	$42,511	$20,087.62	$11,407	$389.39	+$31.1K → PEYE
3	$83,570	$38,082.81	$12,198	$426.53	+$71.4K → PEYE
4	$159,386	$69,966.82	$13,056	$467.62	+$146.3K → PEYE
5	$295,256	$124,712.82	$13,987	$513.12	+$281.3K → PEYE
6	$531,835	$215,911.30	$14,998	$563.56	+$516.8K → PEYE
7	$932,535	$363,471.12	$16,098	$619.52	+$916.4K → PEYE
8	$1,593,439	$595,626.55	$17,295	$681.69	+$1.58M → PEYE
9	$2,656,155	$951,175.34	$18,599	$750.82	+$2.64M → PEYE
10	$4,323,904	$1,481,817.76	$20,022	$827.78	+$4.30M → PEYE

PEYE vs JNJ: Complete Analysis 2026

PEYE — Stock

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Full PEYE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this PEYE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEYE vs SCHD PEYE vs JEPI PEYE vs O PEYE vs KO PEYE vs MAIN PEYE vs ABBV PEYE vs MRK PEYE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.